Insider · CIK 0001591475
David Soergel
Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.). First filing May 18, 2026, latest Jun 1, 2026.
In brief
David Soergel files SEC Form 4 as officer at MDGL (MADRIGAL PHARMACEUTICALS, INC.). Since May 18, 2026, David Soergel has reported 0 open-market buys worth $0 and 2 open-market sells worth $952k, the latest filed on Jun 1, 2026.
A track record needs three past buys with six months of prices behind them; David Soergel has 0, so none is measured yet.
The newest scored trade: sold $517k of MDGL on Jun 1, 2026, filed Jun 1, 2026, scored 21 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $952k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDGL: MADRIGAL PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | MADRIGAL PHARMACEUTICALS, INC. | $517k 1,042 shares | -9% | +76% from low-20% from high | |
| 40Moderate | MADRIGAL PHARMACEUTICALS, INC. | $435k 844 shares | -7% | +95% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 1, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | 1,042 0.00% of outstanding | $518k | Jun 1, 2026 | $435k |
| May 18, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | 844 0.00% of outstanding | $442k | May 18, 2026 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,042 | $495.74 | $517k | 10,033 | Jun 1, 2026 |
| May 18, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -844 | $515.90 | $435k | 11,075 | May 18, 2026 |
| Mar 4, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +4,374 | $0.00 | $0 | 11,919 | Mar 6, 2026 |
| Mar 4, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,467 | $0.00 | $0 | 5,467 | Mar 6, 2026 |
| May 15, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +7,545 | $0.00 | $0 | 7,545 | May 16, 2025 |
| May 15, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +12,839 | $0.00 | $0 | 12,839 | May 16, 2025 |
Questions about David Soergel
Answered from the filings on this page, as of the latest one.
Is David Soergel buying or selling?
In the last 12 months David Soergel reported 0 open-market buys worth $0 and 2 open-market sells worth $952k on SEC Form 4; the latest was sold $517k of MDGL on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.
How did David Soergel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Soergel has 0.
Where does David Soergel file Form 4?
David Soergel has filed Form 4 at MDGL (MADRIGAL PHARMACEUTICALS, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.